Steve Valiquette
Stock Analyst at Barclays
(2.44)
# 2,362
Out of 4,711 analysts
175
Total ratings
49.12%
Success rate
-3.17%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $9.44 | +27.12% | 13 | Oct 31, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Underweight | $7 → $8 | $9.55 | -16.23% | 15 | Oct 16, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $579.74 | +6.25% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $4.44 | +102.70% | 7 | Mar 1, 2024 | |
| HOUS Anywhere Real Estate | Maintains: Underweight | $4.5 → $5 | $3.50 | +42.86% | 3 | Feb 20, 2024 | |
| MPW Medical Properties Trust | Maintains: Overweight | $12 → $10 | $3.86 | +159.07% | 5 | Aug 22, 2023 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $16.88 | +42.18% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $44.36 | +93.87% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $59.58 | +42.67% | 6 | Jul 31, 2023 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $275 → $300 | $303.62 | -1.19% | 4 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $93 → $88 | $84.47 | +4.18% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $35 → $34 | $35.08 | -3.08% | 3 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $105 | $129.46 | -18.89% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $58.76 | -6.40% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $16.96 | -23.35% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $180.11 | -21.16% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $23.70 | -78.90% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $94.45 | -39.65% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $124.64 | -34.21% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $20.12 | -10.54% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $37.83 | -18.05% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $294.73 | +27.24% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $27.36 | -30.56% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $7 | $5.13 | +36.45% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $247.10 | +130.68% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $118.28 | -45.89% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $276.92 | +11.95% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $500.13 | +12.97% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $280 → $240 | $6.02 | +3,886.71% | 2 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $12.78 | +486.85% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $4.19 | +353.46% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $3.16 | +216.46% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $42 → $34 | $21.76 | +56.25% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $4.58 | +336.68% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $131.19 | +98.19% | 1 | Feb 19, 2021 |
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $9.44
Upside: +27.12%
Walgreens Boots Alliance
Oct 16, 2024
Maintains: Underweight
Price Target: $7 → $8
Current: $9.55
Upside: -16.23%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $579.74
Upside: +6.25%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $4.44
Upside: +102.70%
Anywhere Real Estate
Feb 20, 2024
Maintains: Underweight
Price Target: $4.5 → $5
Current: $3.50
Upside: +42.86%
Medical Properties Trust
Aug 22, 2023
Maintains: Overweight
Price Target: $12 → $10
Current: $3.86
Upside: +159.07%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $16.88
Upside: +42.18%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $44.36
Upside: +93.87%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $59.58
Upside: +42.67%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $303.62
Upside: -1.19%
May 5, 2023
Maintains: Equal-Weight
Price Target: $93 → $88
Current: $84.47
Upside: +4.18%
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $35.08
Upside: -3.08%
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $129.46
Upside: -18.89%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $58.76
Upside: -6.40%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $16.96
Upside: -23.35%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $180.11
Upside: -21.16%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $23.70
Upside: -78.90%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $94.45
Upside: -39.65%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $124.64
Upside: -34.21%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $20.12
Upside: -10.54%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $37.83
Upside: -18.05%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $294.73
Upside: +27.24%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $27.36
Upside: -30.56%
Oct 21, 2022
Maintains: Overweight
Price Target: $8 → $7
Current: $5.13
Upside: +36.45%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $247.10
Upside: +130.68%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $118.28
Upside: -45.89%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $276.92
Upside: +11.95%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $500.13
Upside: +12.97%
Nov 11, 2021
Maintains: Equal-Weight
Price Target: $280 → $240
Current: $6.02
Upside: +3,886.71%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $12.78
Upside: +486.85%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $4.19
Upside: +353.46%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $3.16
Upside: +216.46%
May 28, 2021
Downgrades: Underweight
Price Target: $42 → $34
Current: $21.76
Upside: +56.25%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $4.58
Upside: +336.68%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $131.19
Upside: +98.19%